Cargando…

Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis

B ackground: Familial history of multiple sclerosis (MS) has been considered as one of the etiologic factors of MS by several studies. It is valuable to combine the results of these studies. The aim of this study is to estimate the pooled prevalence of familial MS in Iran using meta-analysis. Method...

Descripción completa

Detalles Bibliográficos
Autores principales: Moosazadeh, Mahmood, Esmaeili, Ravanbakhsh, Mehdi Nasehi, Mohammad, Abedi, Ghasem, Afshari, Mahdi, Farshidi, Fereshteh, Kheradmand, Motahareh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526783/
https://www.ncbi.nlm.nih.gov/pubmed/28761631
_version_ 1783252850708578304
author Moosazadeh, Mahmood
Esmaeili, Ravanbakhsh
Mehdi Nasehi, Mohammad
Abedi, Ghasem
Afshari, Mahdi
Farshidi, Fereshteh
Kheradmand, Motahareh
author_facet Moosazadeh, Mahmood
Esmaeili, Ravanbakhsh
Mehdi Nasehi, Mohammad
Abedi, Ghasem
Afshari, Mahdi
Farshidi, Fereshteh
Kheradmand, Motahareh
author_sort Moosazadeh, Mahmood
collection PubMed
description B ackground: Familial history of multiple sclerosis (MS) has been considered as one of the etiologic factors of MS by several studies. It is valuable to combine the results of these studies. The aim of this study is to estimate the pooled prevalence of familial MS in Iran using meta-analysis. Methods: Using relevant keywords, national and international databanks were searched. Considering the significant heterogeneity between the results, random effect model was utilized to estimate the pooled prevalence of familial MS using Stata software. Results: After screening the selected articles, 15 studies with total sample size of 6248 (from 60 to 1718) were identified eligible for final meta-analysis. Overall prevalence of familial MS in Iran was estimated as of 11.4% [95% confidence interval (CI): 8.7-14.1]. Point prevalence varied between 3.3% and 26.7%. Conclusion: Our study showed that the familial prevalence of MS among Iranian people is relatively high. More studies are warranted to investigate the effect of familial history as a risk factor for MS.
format Online
Article
Text
id pubmed-5526783
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-55267832017-07-31 Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis Moosazadeh, Mahmood Esmaeili, Ravanbakhsh Mehdi Nasehi, Mohammad Abedi, Ghasem Afshari, Mahdi Farshidi, Fereshteh Kheradmand, Motahareh Iran J Neurol Review Article B ackground: Familial history of multiple sclerosis (MS) has been considered as one of the etiologic factors of MS by several studies. It is valuable to combine the results of these studies. The aim of this study is to estimate the pooled prevalence of familial MS in Iran using meta-analysis. Methods: Using relevant keywords, national and international databanks were searched. Considering the significant heterogeneity between the results, random effect model was utilized to estimate the pooled prevalence of familial MS using Stata software. Results: After screening the selected articles, 15 studies with total sample size of 6248 (from 60 to 1718) were identified eligible for final meta-analysis. Overall prevalence of familial MS in Iran was estimated as of 11.4% [95% confidence interval (CI): 8.7-14.1]. Point prevalence varied between 3.3% and 26.7%. Conclusion: Our study showed that the familial prevalence of MS among Iranian people is relatively high. More studies are warranted to investigate the effect of familial history as a risk factor for MS. Tehran University of Medical Sciences 2017-04-04 /pmc/articles/PMC5526783/ /pubmed/28761631 Text en Copyright © 2015 Iranian Neurological Association, and Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Moosazadeh, Mahmood
Esmaeili, Ravanbakhsh
Mehdi Nasehi, Mohammad
Abedi, Ghasem
Afshari, Mahdi
Farshidi, Fereshteh
Kheradmand, Motahareh
Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis
title Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis
title_full Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis
title_fullStr Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis
title_full_unstemmed Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis
title_short Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis
title_sort prevalence of familial multiple sclerosis in iran: a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526783/
https://www.ncbi.nlm.nih.gov/pubmed/28761631
work_keys_str_mv AT moosazadehmahmood prevalenceoffamilialmultiplesclerosisiniranasystematicreviewandmetaanalysis
AT esmaeiliravanbakhsh prevalenceoffamilialmultiplesclerosisiniranasystematicreviewandmetaanalysis
AT mehdinasehimohammad prevalenceoffamilialmultiplesclerosisiniranasystematicreviewandmetaanalysis
AT abedighasem prevalenceoffamilialmultiplesclerosisiniranasystematicreviewandmetaanalysis
AT afsharimahdi prevalenceoffamilialmultiplesclerosisiniranasystematicreviewandmetaanalysis
AT farshidifereshteh prevalenceoffamilialmultiplesclerosisiniranasystematicreviewandmetaanalysis
AT kheradmandmotahareh prevalenceoffamilialmultiplesclerosisiniranasystematicreviewandmetaanalysis